Elad Asher: Higher IPF Is Associated with Adverse Outcomes in ICCU
Elad Asher, Head ICCU at Shaare Zedek Medical Center, Jerusalem, shared a post on X about a recent article he and his colleagues co-authored, published in Thrombosis and Haemostasis, adding:
“Pleased to share our new paper in Thrombosis and Haemostasis.
In an unselected ICCU cohort, higher immature platelet fraction was independently associated with adverse outcomes, supporting IPF as a readily available risk marker.”
Title: Immature Platelet Fraction as an Independent Marker of Adverse Outcomes in an Intensive Cardiovascular Care Unit
Authors: Elad Asher, Louay Taha, Mohammad Karmi, Akiva Brin, Pierre Sabouret, Mamas A. Mamas, Noam Fink, Ari Naimark, Amjad Abu-Salman, Michael Glikson
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 12, 2026, 16:40Heghine Khachatryan: From Ideal Protocols to Feasible Pathways in Hemophilia Musculoskeletal Care
-
Sep 12, 2026, 16:33Consuela A. Albright: The Strategic Value of Proclamations in Health Advocacy
-
Sep 12, 2026, 16:28Abdulrahman Al Raizah: Mitapivat for Transfusion-Dependent Thalassemia – The ENERGIZE-T Phase 3 Trial
-
Sep 12, 2026, 16:14Pierre F. Saboret: IPF and Long Term Prognosis Thrombosis and Haemostasis
-
Sep 12, 2026, 15:50Dalip Kumar: ED to Mental Health Unit Transfer Completeness Following Intentional Overdose
-
Sep 12, 2026, 15:15Ali Saad Al-shammari: LAAC vs Medical Therapy for Stroke Prevention in AF
-
Sep 12, 2026, 14:33A New Approach to Transfusion Support – ISBT
-
Sep 12, 2026, 14:32Aref Bin Abdulhak: Diminishing Benefit of IVUS-Guided PCI Over Time – A 23-RCT Meta-Analysis
-
Sep 12, 2026, 14:27Advice to My Younger Self Living With VWD – Haemophilia Foundation Australia